Obtaining models of dementia in mouse strains and their application in the development of new drugs
Keywords:
behavioral tests, cognitive function, Alzheimer's dementiaAbstract
Introduction: Dementia is a clinical syndrome that involves the decline of various cognitive functions.
Objective: To obtain animal models of dementia with mice strains produced in Centro para la production de animales de laboratorio and to demonstrate its usefulness in the development of a formulation for its treatment.
Methods: Young animals of the strains OF1cenp and C57BL/6cenp were evaluated with three compounds that were administered intracerebroventricularly to obtain an Alzheimer-type dementia model. In addition, it was carried out the neurobehavioral, hematological, biochemical and histological characterization of the strains BALB/ccenp, OF1cenp and C57/BL/6cenp of aged mice as a model of dementia. These models were evaluated for the development of the new biologic drug Biocen-128.
Results: OF1cenp strain responded better than the C57BL/6cenp to the Alzheimer's model by administration of streptozotocin and in this model, the anti-neuroinflammatory effect of the BioCen-128 formulation was demonstrated. In the three strains of aged mice there was observed deterioration in cognitive function, in BALB/ccenp and OF1cenp mice an increase in oxidative damage was found; and in BALB/ccenp and C57BL/6cenp there was a decrease in thymus weight. In addition, brain weight decreased in all three strains studied. An increase in nuclear polymorphs and a decrease in lymphocytes were observed in C57BL/6cenp mice. In the BALB/ccenp and C57BL/6cenp strains, the positive effect of BioCen-128 was demonstrated with respect to behavioral, hematological and biochemical parameters.
Conclusions: Male mice of the strain OF1cenp (15-16 months) and BALB/ccenp (12-13 months) and females of the strain C57BL/6cenp (15-16 months), can be used as a model of dementia. The dementia models developed were validated with the application of BioCen-128 since characteristic markers of Alzheimer's dementia were modified.Downloads
Published
How to Cite
Issue
Section
License
The journal Anales de la Academia de Ciencias de Cuba protects copyright, and operates with a Creative Commons License 4.0 (Creative Commons Attribution-NonCommercial License 4.0). By publishing in it, authors allow themselves to copy, reproduce, distribute, publicly communicate their work and generate derivative works, as long as the original author is cited and acknowledged. They do not allow, however, the use of the original work for commercial or lucrative purposes.
The authors authorize the publication of their writings, retaining the authorship rights, and assigning and transferring to the magazine all the rights protected by the intellectual property laws that govern in Cuba, which imply editing to disseminate the work.
Authors may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with recognition of having been first published in this journal.
To learn more, see https://creativecommons.org